Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 7038579, 9 pages
https://doi.org/10.1155/2017/7038579
Research Article

Long Noncoding RNA PVT1 as a Novel Diagnostic Biomarker and Therapeutic Target for Melanoma

1Department of Burn and Plastic Surgery, The 253rd Hospital of PLA, Hohhot, Inner Mongolia 010051, China
2Intensive Care Unit, The 253rd Hospital of PLA, Hohhot, Inner Mongolia 010051, China
3Department of General Surgery, The 253rd Hospital of PLA, Hohhot, Inner Mongolia 010051, China

Correspondence should be addressed to Xiangjun Chen; moc.361@352_jxc

Received 26 September 2016; Revised 18 December 2016; Accepted 21 December 2016; Published 7 February 2017

Academic Editor: Junya Kuroda

Copyright © 2017 Xiangjun Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. A. Torre, F. Bray, R. L. Siegel, J. Ferlay, J. Lortet-Tieulent, and A. Jemal, “Global cancer statistics, 2012,” CA Cancer Journal for Clinicians, vol. 65, no. 2, pp. 87–108, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. J. M. Zaretsky, A. Garcia-Diaz, D. S. Shin et al., “Mutations associated with acquired resistance to PD-1 blockade in melanoma,” New England Journal of Medicine, vol. 375, no. 9, pp. 819–829, 2016. View at Publisher · View at Google Scholar
  3. The Lancet, “Melanoma research gathers momentum,” The Lancet, vol. 385, no. 9985, p. 2323, 2015. View at Publisher · View at Google Scholar
  4. K. S. M. Smalley and V. K. Sondak, “Inhibition of BRAF and MEK in BRAF-mutant melanoma,” The Lancet, vol. 386, no. 9992, pp. 410–412, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. T. K. Burki, “Defining the genetics of melanoma progression,” The Lancet Oncology, vol. 17, no. 1, article e7, 2016. View at Publisher · View at Google Scholar
  6. P. J. Batista and H. Y. Chang, “Long noncoding RNAs: cellular address codes in development and disease,” Cell, vol. 152, no. 6, pp. 1298–1307, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. C. P. Ponting, P. L. Oliver, and W. Reik, “Evolution and functions of long noncoding RNAs,” Cell, vol. 136, no. 4, pp. 629–641, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. J.-H. Yuan, F. Yang, F. Wang et al., “A long noncoding RNA activated by TGF-β promotes the invasion-metastasis cascade in hepatocellular carcinoma,” Cancer Cell, vol. 25, no. 5, pp. 666–681, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Lin, C. Li, Z. Xing et al., “The LINK-A lncRNA activates normoxic HIF1α signalling in triple-negative breast cancer,” Nature Cell Biology, vol. 18, no. 2, pp. 213–224, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. E. Leucci, R. Vendramin, M. Spinazzi et al., “Melanoma addiction to the long non-coding RNA SAMMSON,” Nature, vol. 531, no. 7595, pp. 518–522, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Arrigo and A. Pulliero, “Effect of environmental chemical stress on nuclear noncoding RNA involved in epigenetic control,” BioMed Research International, vol. 2015, Article ID 761703, 10 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. X. Zhou, C. Yin, Y. Dang, F. Ye, and G. Zhang, “Identification of the long non-coding RNA H19 in plasma as a novel biomarker for diagnosis of gastric cancer,” Scientific Reports, vol. 5, Article ID 11516, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Tantai, D. Hu, Y. Yang, and J. Geng, “Combined identification of long non-coding RNA XIST and HIF1A-AS1 in serum as an effective screening for non-small cell lung cancer,” International Journal of Clinical and Experimental Pathology, vol. 8, no. 7, pp. 7887–7895, 2015. View at Google Scholar
  14. F. Wang, J.-H. Yuan, S.-B. Wang et al., “Oncofetal long noncoding RNA PVT1 promotes proliferation and stem cell-like property of hepatocellular carcinoma cells by stabilizing NOP2,” Hepatology, vol. 60, no. 4, pp. 1278–1290, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. L. Wan, M. Sun, G.-J. Liu et al., “Long noncoding RNA PVT1 promotes non-small cell lung cancer cell proliferation through epigenetically regulating LATS2 expression,” Molecular Cancer Therapeutics, vol. 15, no. 5, pp. 1082–1094, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Guan, W.-L. Kuo, J. L. Stilwell et al., “Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer,” Clinical Cancer Research, vol. 13, no. 19, pp. 5745–5755, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Iden, S. Fye, K. Li, T. Chowdhury, R. Ramchandran, and J. S. Rader, “The lncRNA PVT1 contributes to the cervical cancer phenotype and associates with poor patient prognosis,” PLoS ONE, vol. 11, no. 5, Article ID e0156274, 2016. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Haqq, M. Nosrati, D. Sudilovsky et al., “The gene expression signatures of melanoma progression,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 17, pp. 6092–6097, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. A. P. Smith, K. Hoek, and D. Becker, “Whole-genome expression profiling of the melanoma progression pathway reveals marked molecular differences between nevi/melanoma in situ and advanced-stage melanomas,” Cancer Biology and Therapy, vol. 4, no. 9, pp. 1018–1029, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Jin, W. Shi, F. Wang et al., “Long non-coding RNA HULC as a novel serum biomarker for diagnosis and prognosis prediction of gastric cancer,” Oncotarget, vol. 7, no. 32, pp. 51763–51771, 2016. View at Publisher · View at Google Scholar · View at Scopus
  21. Y.-S. Tong, X.-W. Wang, X.-L. Zhou et al., “Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma,” Molecular Cancer, vol. 14, article 3, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. V. Brower, “Combination immunotherapy breakthrough for melanoma,” The Lancet Oncology, vol. 16, no. 7, article e318, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Bowyer and P. Lorigan, “The place of PD-1 inhibitors in melanoma management,” The Lancet Oncology, vol. 16, no. 8, pp. 873–874, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Bhattacharjee, K. Renganaath, R. Mehrotra, and S. Mehrotra, “Combinatorial control of gene expression,” BioMed Research International, vol. 2013, Article ID 407263, 11 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. X. Zhu, J. Yuan, T. Zhu, Y. Li, and X. Cheng, “Long noncoding RNA glypican 3 (GPC3) antisense transcript 1 promotes hepatocellular carcinoma progression via epigenetically activating GPC3,” The FEBS Journal, vol. 283, no. 20, pp. 3739–3754, 2016. View at Publisher · View at Google Scholar
  26. W. Gao, J. Y.-W. Chan, and T.-S. Wong, “Long non-coding RNA deregulation in tongue squamous cell carcinoma,” BioMed Research International, vol. 2014, Article ID 405860, 10 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. M. M. Kamel, M. Matboli, M. Sallam, I. F. Montasser, A. S. Saad, and A. H. F. El-Tawdi, “Investigation of long noncoding RNAs expression profile as potential serum biomarkers in patients with hepatocellular carcinoma,” Translational Research, vol. 168, pp. 134–145, 2016. View at Publisher · View at Google Scholar · View at Scopus
  28. L. Dong, P. Qi, M.-D. Xu et al., “Circulating CUDR, LSINCT-5 and PTENP1 long noncoding RNAs in sera distinguish patients with gastric cancer from healthy controls,” International Journal of Cancer, vol. 137, no. 5, pp. 1128–1135, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. C. G. H. Rönnau, G. W. Verhaegh, M. V. Luna-Velez, and J. A. Schalken, “Noncoding RNAs as novel biomarkers in prostate cancer,” BioMed Research International, vol. 2014, Article ID 591703, 17 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Zhang, G. Zhang, and J. Liu, “Long noncoding RNA PVT1 promotes cervical cancer progression through epigenetically silencing miR-200b,” APMIS, vol. 124, no. 8, pp. 649–658, 2016. View at Publisher · View at Google Scholar · View at Scopus
  31. C. Ding, Z. Yang, Z. Lv et al., “Long non-coding RNA PVT1 is associated with tumor progression and predicts recurrence in hepatocellular carcinoma patients,” Oncology Letters, vol. 9, no. 2, pp. 955–963, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. C. Huang, W. Yu, Q. Wang et al., “Increased expression of the lncRNA PVT1 is associated with poor prognosis in pancreatic cancer patients,” Minerva Medica, vol. 106, no. 3, pp. 143–149, 2015. View at Google Scholar
  33. R. Kong, E.-B. Zhang, D.-D. Yin et al., “Long noncoding RNA PVT1 indicates a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically regulating p15 and p16,” Molecular Cancer, vol. 14, no. 1, article 82, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Ding, D. Li, M. Gong et al., “Expression and clinical significance of the long non-coding RNA PVT1 in human gastric cancer,” OncoTargets and Therapy, vol. 7, pp. 1625–1630, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. Y.-R. Yang, S.-Z. Zang, C.-L. Zhong, Y.-X. Li, S.-S. Zhao, and X.-J. Feng, “Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer,” International Journal of Clinical and Experimental Pathology, vol. 7, no. 10, pp. 6929–6935, 2014. View at Google Scholar · View at Scopus
  36. D. Cui, C.-H. Yu, M. Liu, Q.-Q. Xia, Y.-F. Zhang, and W.-L. Jiang, “Long non-coding RNA PVT1 as a novel biomarker for diagnosis and prognosis of non-small cell lung cancer,” Tumor Biology, vol. 37, no. 3, pp. 4127–4134, 2016. View at Publisher · View at Google Scholar · View at Scopus
  37. Y. Takahashi, G. Sawada, J. Kurashige et al., “Amplification of PVT-1 is involved in poor prognosis via apoptosis inhibition in colorectal cancers,” British Journal of Cancer, vol. 110, no. 1, pp. 164–171, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. X.-W. Zhang, P. Bu, L. Liu, X.-Z. Zhang, and J. Li, “Overexpression of long non-coding RNA PVT1 in gastric cancer cells promotes the development of multidrug resistance,” Biochemical and Biophysical Research Communications, vol. 462, no. 3, pp. 227–232, 2015. View at Publisher · View at Google Scholar · View at Scopus
  39. E. Liu, Z. Liu, Y. Zhou, R. Mi, and D. Wang, “Overexpression of long non-coding RNA PVT1 in ovarian cancer cells promotes cisplatin resistance by regulating apoptotic pathways,” International Journal of Clinical and Experimental Medicine, vol. 8, no. 11, pp. 20565–20572, 2015. View at Google Scholar · View at Scopus